April 2, 2019 /

Italfarmaco Provides Givinostat Update (March 2019)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Italfarmaco Provides Givinostat Update (March 2019)

Italfarmaco joined PPMD for a webinar on March 27, 2019 to update the community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo